Detalhe da pesquisa
1.
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
Oncologist
; 28(4): 333-340, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576173
2.
Targeting HIF-2 Alpha in Renal Cell Carcinoma.
Curr Treat Options Oncol
; 24(9): 1183-1198, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403008
3.
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 20(10): 1386-1394, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427205
4.
Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
Am J Hematol
; 89(2): 168-73, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123154
5.
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
; 22(2): 92-97, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932205
6.
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events.
Clin Genitourin Cancer
; 22(2): 368-379, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245437
7.
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
J Immunother Cancer
; 12(4)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604810
8.
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948504
9.
Clinical Review on the Management of Metastatic Renal Cell Carcinoma.
JCO Oncol Pract
; 18(3): 187-196, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529499
10.
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors.
Target Oncol
; 17(5): 563-569, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986816
11.
Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.
Eur Urol
; 81(6): 555-558, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980496
12.
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma.
J Immunother Cancer
; 10(10)2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252996
13.
Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma.
Curr Oncol
; 28(6): 5019-5024, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940060
14.
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599022
15.
Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.
Curr Oncol
; 28(3): 1921-1926, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34065284
16.
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.
Target Oncol
; 16(5): 633-642, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379283
17.
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy.
Target Oncol
; 16(6): 813-821, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741719
18.
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab.
J Immunother Cancer
; 9(9)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518292
19.
Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage Migration.
Clin Genitourin Cancer
; 19(1): e12-e16, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32800474
20.
Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches.
Cancer J
; 26(5): 441-447, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947312